Can pan-immune inflammation value and systemic inflammatory response index be used clinically to predict inflammation in patients with cataract
dc.contributor.author | Akbulut Yağcı, Betül | |
dc.contributor.author | Erdal, Hüseyin | |
dc.date.accessioned | 2024-05-03T06:28:01Z | |
dc.date.available | 2024-05-03T06:28:01Z | |
dc.date.issued | 2023 | |
dc.department | Tıp Fakültesi | |
dc.description.abstract | Aim: It is known that inflammatory processes increase the risk of cataract formation. There are no studies examining inflammatory indices in patients with cataract. Therefore, this is the first study that simultaneously investigates the systemic inflammatory response index (SIRI) and pan-immune-inflammation value (PIV) in patients with cataract. Material and Methods: Ninety-five patients and 80 healthy controls who were examined at the Ophthalmology clinics of Aksaray University Education and Research Hospital between January 2022 and January 2023 were included in this retrospective study. The neutrophil-to-lymphocyte ratio (NLR), platelet-tolymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), systemic immune-inflammation index (SII), SIRI and PIV values were calculated as indicators of the inflammatory process. Results: The mean age of the patients was 68.3 +/- 12.1 years and 54.7% of cataract patients were females. In the control group, the mean age was 66.5 +/- 5.4 years, and 32.5% of the participants were females. There was no significant difference between the patient and control groups in terms of laboratory parameters (p>0.05). In addition, inflammatory indices were calculated for the patient and control groups. No statistically significant difference was found between NLR, PLR, LMR, SII, SIRI, and PIV between the groups (p>0.05). Discussion: This study indicates that SIRI and PIV can be used in the evaluation of cataract patients. Therefore, Hemogram parameters and inflammatory indexes created with their combination may contribute to monitoring the progression of cataracts. | |
dc.identifier.endpage | 1067 | en_US |
dc.identifier.issn | 2667-663X | |
dc.identifier.issue | 12 | en_US |
dc.identifier.startpage | 1064 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12451/11757 | |
dc.identifier.volume | 14 | en_US |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.language.iso | en | |
dc.publisher | Bayrakol Medical Publishing | |
dc.relation.ispartof | Annals of Clinical and Analytical Medicine | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Cataracts | |
dc.subject | Inflammation | |
dc.subject | Systemic Inflammatory Response Index | |
dc.subject | Pan-Immune-Inflammation Value | |
dc.title | Can pan-immune inflammation value and systemic inflammatory response index be used clinically to predict inflammation in patients with cataract | |
dc.type | Article |